Skip to content
iVascular logo — From the heart

iVascular

From the heart

Founded 2010 Germany Germany 307 employees Biotechnology, Health Care +2

General Information

Company Name iVascular
Founded Year 2010
Location Germany Germany
Employees 307
Industries Biotechnology, Health Care, Health and Wellness +1
Business Model B2B, B2G, B2B2C
Revenue Model Product Sales, One Time Purchase, Tiered Pricing
Social

BounceWatch is an independent company data service, not affiliated with iVascular. To contact iVascular, visit ivascular.global.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

How does iVascular compare?

A PDF of iVascular and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.

See a sample report

This takes a few seconds: we look beyond our own index too.

Meeting iVascular soon?

A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample

About iVascular

iVascular, founded in 2010 and headquartered in Germany, is a pioneering force in the Biotechnology and Medical Devices sector. Their mission, encapsulated in the slogan “Therapies for living,” is to create cutting-edge medical devices and therapies that address cardiovascular disorders effectively.

One of the standout features of iVascular is its robust vertical integration strategy. The company excels in transforming basic raw materials such as plastics and metals into advanced cardiovascular devices. This seamless integration from design to production ensures high-quality standards and efficiency.

The company's innovation is driven by a diverse team skilled in biopolymers, coatings, and drug delivery systems. iVascular oversees an expansive technology center featuring over 1000 m² of ISO standard clean rooms, supporting their substantial capabilities in R&D and production.

With a presence in more than 70 countries, iVascular has established an extensive global footprint, offering a comprehensive range of products for interventional cardiology and endovascular procedures.

Business keywords: Innovative Medical Devices, Cardiovascular System Treatments, Biopolymer Expertise, Drug Delivery Systems, Medical Device Development, Cardiovascular Implants, Vertical Integration, Quality Standards, Clean Room Facilities, Research and Development, Interventional Cardiology, Endovascular Procedures, Drug Eluting Stents, Drug Coated Balloons, Global Sales Network

Services & Products

development of cardiovascular devices
manufacturing of drug-eluting stents
clinical research and trials
innovative medical technologies

Target Customers

hospitals cardiologists vascular surgeons healthcare professionals

No funding data available for iVascular yet.

iVascular Alternatives & Competitors

View All Alternatives
iVascular vs

Pioneering advanced cardiovascular medical devices for life-saving heart treatments.

Private Equity
201-500 employees
Health Care, Manufacturing
iVascular vs

Scoprire significa vedere quello che tutti vedono e pensare quello che nessuno ha ancora pensato.” A...

28 employees
Health Care, Medical Devices
iVascular vs

Innovative solutions for advanced cardiovascular specialty catheters in Interventional Cardiology, E...

Venture round
Health Care, Medical Devices

FAQ About iVascular

From the heart
iVascular was founded in 2010.
iVascular is headquartered in Germany.
iVascular operates in Biotechnology, Health Care, Health and Wellness and Medical Devices. Its work centres on Innovative Medical Devices, Cardiovascular System Treatments, Biopolymer Expertise and Drug Delivery Systems. Its customers include hospitals, cardiologists and vascular surgeons.
iVascular has a B2B, B2G and B2B2C business model. Its revenue comes from Product Sales, One Time Purchase and Tiered Pricing.
iVascular has approximately 307 employees.
iVascular offers: development of cardiovascular devices, manufacturing of drug-eluting stents, clinical research and trials, innovative medical technologies.
Top alternatives and competitors to iVascular include Relisys, aptiva medical srl, Roxwood Medical, Conformis - acquired by restor3d, Gothia Medical AB. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
iVascular and Relisys are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for iVascular, https://bouncewatch.com/company/ivascular, updated 25 September 2026. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Talk to an analyst Book a 7-day Readout